Chronic Therapy With a Partial Adenosine A1-Receptor Agonist Improves Left Ventricular Function and Remodeling in Dogs With Advanced Heart Failure
- 1 May 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 6 (3) , 563-571
Abstract
Background—: Adenosine elicits cardioprotection through A1-receptor activation. Therapy with adenosine A1-receptor agonists, however, is limited by undesirable actions of full agonism, such as bradycardia. This study examined the effects of capadenoson (CAP), a partial adenosine A1-receptor agonist, on left ventricular (LV) function and remodeling in dogs with heart failure. Methods and Results—: Twelve dogs with microembolization-induced heart failure were randomized to 12 weeks oral therapy with CAP (7.5 mg BID; n=6) or to no therapy (control; n=6). LV end-diastolic and end-systolic volumes, ejection fraction, plasma norepinephrine, and n-terminal pro–brain natriuretic peptide were measured before (pre) and 1 and 12 weeks after therapy (post). LV tissue obtained at post was used to assess volume fraction of interstitial fibrosis, sarcoplasmic reticulum calcium ATPase-2a activity, expression of mitochondria uncoupling proteins (UCP) and glucose transporters (GLUT). In controls, end-diastolic and end-systolic volumes increased and ejection fraction decreased significantly from pre to post (ejection fraction, 30±2 versus 27±1%; P P P <0.05), whereas end-systolic volume decreased. CAP significantly decreased volume fraction of interstitial fibrosis, normalized sarcoplasmic reticulum calcium ATPase-2a activity and expression of UCP-2 and UCP-3, and GLUT-1 and GLUT-2 and significantly decreased plasma norepinephrine and n-terminal pro–brain natriuretic peptide. Conclusions—: In heart failure dogs, CAP improves LV function and prevents progressive remodeling. Improvement of LV systolic function occurs early after initiating therapy. The results support development of partial adenosine A1-receptor agonists for the treatment of chronic heart failure.Keywords
This publication has 49 references indexed in Scilit:
- Partial adenosine A1 receptor agonists for cardiovascular therapiesPurinergic Signalling, 2011
- Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Selective Attenuation of Norepinephrine Release and Stress-Induced Heart Rate Increase by Partial Adenosine A1 AgonismPLOS ONE, 2011
- Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generationCancer Chemotherapy and Pharmacology, 2010
- Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac Electrophysiology2009
- Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failureJournal of Molecular and Cellular Cardiology, 2007
- Species comparison of adenosine and β-adrenoceptors in mammalian atrial and ventricular myocardiumEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Mitochondrial abnormalities in myocardium of dogs with chronic heart failureJournal of Molecular and Cellular Cardiology, 1992
- Usefulness and limitations of radiographic methods for determining left ventricular volumeThe American Journal of Cardiology, 1966